Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Bone Marrow Transplantation
|
November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
M Y Detrait, S Morisset, R Peffault de Latour, et al.
Bone Marrow Transplantation
|
June 12, 2002
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy
S Vigouroux, N Milpied, J M Andrieu, et al.
Bone Marrow Transplantation
|
September 15, 2015
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
R Peffault de Latour, M Labopin, J Cornelissen, et al.
Bone Marrow Transplantation
|
December 1, 2015
Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT
X Cahu, M Labopin, S Giebel, et al.
Leukemia
|
February 14, 2015
HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM
M Robin, R Porcher, L Adès, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
A Le Bourgeois, M Labopin, D Blaise, et al.
Bone Marrow Transplantation
|
March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes
R Martino, A Henseler, M van Lint, et al.
Bone Marrow Transplantation
|
June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
S Nguyen, A Achour, L Souchet, et al.
Bone Marrow Transplantation
|
November 24, 2015
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
A C Mamez, V Lévy, P Chevallier, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Bone Marrow Transplantation
|
November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
M Y Detrait, S Morisset, R Peffault de Latour, et al.
Bone Marrow Transplantation
|
June 12, 2002
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy
S Vigouroux, N Milpied, J M Andrieu, et al.
Bone Marrow Transplantation
|
September 15, 2015
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
R Peffault de Latour, M Labopin, J Cornelissen, et al.
Bone Marrow Transplantation
|
December 1, 2015
Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT
X Cahu, M Labopin, S Giebel, et al.
Leukemia
|
February 14, 2015
HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM
M Robin, R Porcher, L Adès, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
A Le Bourgeois, M Labopin, D Blaise, et al.
Bone Marrow Transplantation
|
March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes
R Martino, A Henseler, M van Lint, et al.
Bone Marrow Transplantation
|
June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
S Nguyen, A Achour, L Souchet, et al.
Bone Marrow Transplantation
|
November 24, 2015
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
A C Mamez, V Lévy, P Chevallier, et al.
Page
of 3